ASX - By Stock
|
GMV |
Re:
GMVD - NASDAQ IPO
|
|
JG22
|
1.9K |
681K |
1 |
23/10/20 |
23/10/20 |
ASX - By Stock
|
1.9K
|
681K
|
1
|
|
ASX - By Stock
|
GMV |
Re:
Ann: Notice of Extraordinary General Meeting
|
|
JG22
|
29 |
9.8K |
3 |
22/10/20 |
22/10/20 |
ASX - By Stock
|
29
|
9.8K
|
3
|
|
ASX - By Stock
|
GMV |
Re:
NASDAQ: GMVD
|
|
JG22
|
61 |
19K |
4 |
21/10/20 |
21/10/20 |
ASX - By Stock
|
61
|
19K
|
4
|
|
ASX - By Stock
|
GMV |
Re:
Ann: General Meeting Dial-In Details
|
|
JG22
|
95 |
25K |
1 |
14/10/20 |
14/10/20 |
ASX - By Stock
|
95
|
25K
|
1
|
|
ASX - By Stock
|
GMV |
Re:
Ann: G Medical Files Registration Statement with US SEC
|
|
JG22
|
241 |
76K |
3 |
09/10/20 |
09/10/20 |
ASX - By Stock
|
241
|
76K
|
3
|
|
ASX - By Stock
|
GMV |
Re:
Ann: ASX Confirms G Medical Delisting
|
|
JG22
|
355 |
100K |
1 |
08/10/20 |
08/10/20 |
ASX - By Stock
|
355
|
100K
|
1
|
|
ASX - By Stock
|
GMV |
Re:
GMV & HSC
|
|
JG22
|
7 |
3.1K |
1 |
07/10/20 |
07/10/20 |
ASX - By Stock
|
7
|
3.1K
|
1
|
|
ASX - By Stock
|
GMV |
Re:
News: GMV G Medical Innovations Holdings Files For U.S. IPO Of Upto 5 Million Ordinary Shares
|
|
JG22
|
11 |
3.9K |
8 |
02/10/20 |
02/10/20 |
ASX - By Stock
|
11
|
3.9K
|
8
|
|
ASX - By Stock
|
GMV |
Re:
Ann: ASX Confirms G Medical Delisting
|
|
JG22
|
355 |
100K |
5 |
17/09/20 |
17/09/20 |
ASX - By Stock
|
355
|
100K
|
5
|
|
ASX - By Stock
|
GMV |
Re:
Ann: ASX Confirms G Medical Delisting
|
|
JG22
|
355 |
100K |
0 |
17/09/20 |
17/09/20 |
ASX - By Stock
|
355
|
100K
|
0
|
|
ASX - By Stock
|
GMV |
Re:
Ann: G Medical seeks delisting to pursue Q4 NASDAQ listing
|
|
JG22
|
687 |
184K |
2 |
13/08/20 |
13/08/20 |
ASX - By Stock
|
687
|
184K
|
2
|
|
ASX - By Stock
|
GMV |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
JG22
|
55 |
17K |
10 |
31/07/20 |
31/07/20 |
ASX - By Stock
|
55
|
17K
|
10
|
|
ASX - By Stock
|
GMV |
Re:
Ann: Update on continued expansion of IDTF platform in USA
|
|
JG22
|
131 |
38K |
8 |
31/07/20 |
31/07/20 |
ASX - By Stock
|
131
|
38K
|
8
|
|
ASX - By Stock
|
GMV |
Re:
Ann: Update on continued expansion of IDTF platform in USA
|
|
JG22
|
131 |
38K |
5 |
30/07/20 |
30/07/20 |
ASX - By Stock
|
131
|
38K
|
5
|
|
ASX - By Stock
|
GMV |
Re:
GMV The Future
|
|
JG22
|
3.0K |
1.7M |
3 |
23/07/20 |
23/07/20 |
ASX - By Stock
|
3.0K
|
1.7M
|
3
|
|
ASX - By Stock
|
GMV |
Re:
Ann: Four US university hospitals deploy GMV's IDTF platform
|
|
JG22
|
172 |
37K |
6 |
16/07/20 |
16/07/20 |
ASX - By Stock
|
172
|
37K
|
6
|
|
ASX - By Stock
|
GMV |
Re:
Ann: Four US university hospitals deploy GMV's IDTF platform
|
|
JG22
|
172 |
37K |
8 |
16/07/20 |
16/07/20 |
ASX - By Stock
|
172
|
37K
|
8
|
|
ASX - By Stock
|
GMV |
Re:
Ann: Trading Halt
|
|
JG22
|
86 |
34K |
13 |
19/05/20 |
19/05/20 |
ASX - By Stock
|
86
|
34K
|
13
|
|
ASX - By Stock
|
GMV |
Re:
Ann: Trading Halt
|
|
JG22
|
86 |
34K |
1 |
19/05/20 |
19/05/20 |
ASX - By Stock
|
86
|
34K
|
1
|
|
ASX - By Stock
|
GMV |
Re:
Ann: Prospectus
|
|
JG22
|
14 |
4.9K |
1 |
08/05/20 |
08/05/20 |
ASX - By Stock
|
14
|
4.9K
|
1
|
|
ASX - By Stock
|
GMV |
Re:
Ann: Distribution agreement with All County Health Care in USA
|
|
JG22
|
61 |
17K |
11 |
06/05/20 |
06/05/20 |
ASX - By Stock
|
61
|
17K
|
11
|
|
ASX - By Stock
|
GMV |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
JG22
|
24 |
8.3K |
3 |
01/05/20 |
01/05/20 |
ASX - By Stock
|
24
|
8.3K
|
3
|
|
ASX - By Stock
|
GMV |
Re:
GMV Trading 2020
|
|
JG22
|
122 |
46K |
16 |
27/04/20 |
27/04/20 |
ASX - By Stock
|
122
|
46K
|
16
|
|
ASX - By Stock
|
GMV |
Re:
Delisting from ASX?
|
|
JG22
|
6 |
2.2K |
5 |
27/04/20 |
27/04/20 |
ASX - By Stock
|
6
|
2.2K
|
5
|
|
ASX - By Stock
|
GMV |
Re:
Delisting from ASX?
|
|
JG22
|
6 |
2.2K |
5 |
27/04/20 |
27/04/20 |
ASX - By Stock
|
6
|
2.2K
|
5
|
|
ASX - By Stock
|
GMV |
Re:
FDA grants Prizma Over-the-Counter (OTC) Authorisation in USA
|
|
JG22
|
24 |
9.4K |
17 |
15/04/20 |
15/04/20 |
ASX - By Stock
|
24
|
9.4K
|
17
|
|
ASX - By Stock
|
GMV |
Re:
Ann: Corporate and Business Update
|
|
JG22
|
94 |
28K |
4 |
14/04/20 |
14/04/20 |
ASX - By Stock
|
94
|
28K
|
4
|
|
ASX - By Stock
|
GMV |
Re:
Ann: Controlled Placement Agreement
|
|
JG22
|
29 |
13K |
7 |
09/04/20 |
09/04/20 |
ASX - By Stock
|
29
|
13K
|
7
|
|
ASX - By Stock
|
GMV |
Re:
Ann: FDA grants Prizma Over-the-Counter Authorisation in USA
|
|
JG22
|
172 |
76K |
8 |
09/04/20 |
09/04/20 |
ASX - By Stock
|
172
|
76K
|
8
|
|
ASX - By Stock
|
GMV |
Re:
Top Shareholders - GMV
|
|
JG22
|
57 |
20K |
1 |
09/04/20 |
09/04/20 |
ASX - By Stock
|
57
|
20K
|
1
|
|
ASX - By Stock
|
GMV |
Re:
GMV - Fundamental Analysis
|
|
JG22
|
407 |
167K |
7 |
09/04/20 |
09/04/20 |
ASX - By Stock
|
407
|
167K
|
7
|
|
ASX - By Stock
|
GMV |
Re:
GMV - Fundamental Analysis
|
|
JG22
|
407 |
167K |
6 |
09/04/20 |
09/04/20 |
ASX - By Stock
|
407
|
167K
|
6
|
|
ASX - By Stock
|
GMV |
Re:
Ann: FDA grants Prizma Over-the-Counter Authorisation in USA
|
|
JG22
|
172 |
76K |
10 |
08/04/20 |
08/04/20 |
ASX - By Stock
|
172
|
76K
|
10
|
|
ASX - By Stock
|
GMV |
Re:
Ann: FDA grants Prizma Over-the-Counter Authorisation in USA
|
|
JG22
|
172 |
76K |
6 |
08/04/20 |
08/04/20 |
ASX - By Stock
|
172
|
76K
|
6
|
|
ASX - By Stock
|
GMV |
Re:
Ann: Pause in Trade
|
|
JG22
|
36 |
10K |
4 |
08/04/20 |
08/04/20 |
ASX - By Stock
|
36
|
10K
|
4
|
|
ASX - By Stock
|
GMV |
Re:
Ann: Extension of Convertible Notes Settlement Repayment Date
|
|
JG22
|
15 |
5.0K |
12 |
07/04/20 |
07/04/20 |
ASX - By Stock
|
15
|
5.0K
|
12
|
|
ASX - By Stock
|
GMV |
Re:
Ann: Update on Voluntary Suspension and Annual Report Lodgement
|
|
JG22
|
128 |
36K |
3 |
07/04/20 |
07/04/20 |
ASX - By Stock
|
128
|
36K
|
3
|
|
ASX - By Stock
|
GMV |
Re:
Ann: Suspension from Official Quotation
|
|
JG22
|
14 |
3.7K |
3 |
31/03/20 |
31/03/20 |
ASX - By Stock
|
14
|
3.7K
|
3
|
|
ASX - By Stock
|
GMV |
Re:
Ann: Completed Capital Raising
|
|
JG22
|
100 |
165K |
1 |
18/02/20 |
18/02/20 |
ASX - By Stock
|
100
|
165K
|
1
|
|
ASX - By Stock
|
GMV |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
JG22
|
58 |
27K |
0 |
04/02/20 |
04/02/20 |
ASX - By Stock
|
58
|
27K
|
0
|
|
ASX - By Stock
|
GMV |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
JG22
|
58 |
27K |
0 |
04/02/20 |
04/02/20 |
ASX - By Stock
|
58
|
27K
|
0
|
|
ASX - By Stock
|
GMV |
Re:
Ann: Prizma Clinical Trials Completed for China Approval Process
|
|
JG22
|
149 |
81K |
0 |
31/01/20 |
31/01/20 |
ASX - By Stock
|
149
|
81K
|
0
|
|
ASX - By Stock
|
GMV |
Re:
GMV Trading 2020
|
|
JG22
|
122 |
46K |
2 |
31/01/20 |
31/01/20 |
ASX - By Stock
|
122
|
46K
|
2
|
|
ASX - By Stock
|
GMV |
Re:
GMV - Fundamental Analysis
|
|
JG22
|
407 |
167K |
3 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
407
|
167K
|
3
|
|
ASX - By Stock
|
GMV |
Re:
GMV Trading 2020
|
|
JG22
|
122 |
46K |
4 |
21/01/20 |
21/01/20 |
ASX - By Stock
|
122
|
46K
|
4
|
|
ASX - By Stock
|
GMV |
Re:
Ann: Taiwan FDA Approval Granted for Prizma
|
|
JG22
|
89 |
47K |
9 |
20/01/20 |
20/01/20 |
ASX - By Stock
|
89
|
47K
|
9
|
|
ASX - By Stock
|
GMV |
Re:
Ann: Prizma Clinical Trials Completed for China Approval Process
|
|
JG22
|
149 |
81K |
11 |
20/01/20 |
20/01/20 |
ASX - By Stock
|
149
|
81K
|
11
|
|
ASX - By Stock
|
GMV |
Re:
Ann: Prizma Clinical Trials Completed for China Approval Process
|
|
JG22
|
149 |
81K |
1 |
17/01/20 |
17/01/20 |
ASX - By Stock
|
149
|
81K
|
1
|
|
ASX - By Stock
|
GMV |
Re:
Ann: G Medical Secures $30 million Funding Facility
|
|
JG22
|
220 |
99K |
1 |
05/12/19 |
05/12/19 |
ASX - By Stock
|
220
|
99K
|
1
|
|
ASX - By Stock
|
GMV |
Re:
Ann: G Medical Secures $30 million Funding Facility
|
|
JG22
|
220 |
99K |
10 |
05/12/19 |
05/12/19 |
ASX - By Stock
|
220
|
99K
|
10
|
|